MentionFox
Home › Layoffs › BioXcel Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

BioXcel Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in BioXcel Therapeutics, Inc.

MentionFox check on BioXcel Therapeutics, Inc.: 1 red flag found in 2 sources (checked 14 November 2026). mentionfox.com/c/layoffs/bioxcel-therapeutics

  • Bankruptcy filing disclosed Aug 2026 (filing)
  • Note: Layoff plan disclosed Sep 2024 (about 15 employees) (filing)

New since last check: Layoff plan disclosed Sep 2024 (about 15 employees) (filing, first seen 14 November 2026).

Check BioXcel Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about BioXcel Therapeutics, Inc.?

Every exit or restructuring plan BioXcel Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 15 employees are affected, about 28% of its workforce, according to BioXcel Therapeutics, Inc.'s latest layoff filing, on September 19, 2024. As of November 14, 2026, BioXcel Therapeutics, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 19, 2024).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Qatar Investment Authority also filed stake reports on 12 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of BioXcel Therapeutics, Inc.

Free to see. No signup.

People from BioXcel Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the BioXcel Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees15
Latest filing2024-09-19

BioXcel Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did BioXcel Therapeutics have layoffs in 2024? What its filings say

BioXcel Therapeutics, Inc. (CIK 1720893) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2024-09-19

Employees affected

On September 17, 2024, the Board of Directors (the "Board") of BioXcel Therapeutics, Inc. (the "Company") approved a plan to reduce its workforce by 15 employees, or approximately 28% of the Company's headcount (the "Clinical Prioritization"), in order to extend its cash runway and prioritize investment on the clinical development of its lead neuroscience asset, BXCL501.

Expected charges

The Company estimates that it will incur aggregate charges in connection with the Clinical Prioritization of approximately $1.4 million, which relate primarily to severance payments, notice pay and related continuation of benefits costs, all of which are expected to be paid in cash and anticipated to result in future cash expenditures, along with the payment of accrued benefits (such as paid-time-off).

Timing

The Company expects that the majority of these costs will be incurred, and the Clinical Prioritization is expected to be completed, during the quarter ending December 31, 2024.

Also on the record for BioXcel Therapeutics, Inc.

DateRecordFigureOur pageSource
October 30, 2026Leadership change: Samir Saleem appointed, President, and 1 more—Leadership changesSource
August 14, 2026Stake report, Schedule 13G/A, by Armistice Capital, LLC4.99% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G, by Armistice Capital, LLC7.05% of the class5%+ stakesSource
March 30, 2026Stake report, Schedule 13G/A, by Qatar Investment Authority0.6% of the class5%+ stakesSource
February 9, 2026Stake report, Schedule 13G/A, by Integrated Core Strategies (US) LLC8.4% of the class5%+ stakesSource
October 1, 2025Stake report, Schedule 13G, by Integrated Core Strategies (US) LLC5.2% of the class5%+ stakesSource

Keep reading

More on BioXcel Therapeutics, Inc. and the records around it.

BioXcel Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with BioXcel Therapeutics, Inc.?

Want the whole picture on BioXcel Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on BioXcel Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on BioXcel Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    8 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for BioXcel Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/bioxcel-therapeutics
Last updated 2026-11-14
BioXcel Therapeutics, Inc. layoffs 2024: about 15 jobs (8-K). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/bioxcel-therapeutics